Loan and Security Agreements - Additional Information (Details) - USD ($) |
3 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|
Dec. 20, 2024 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Debt Instrument [Line Items] | |||||
| Debt instrument drew | $ 32,500,000 | $ 32,500,000 | |||
| Silicon Valley Bank [Member] | |||||
| Debt Instrument [Line Items] | |||||
| Principal amount | $ 52,500,000 | ||||
| Debt instrument drew | 32,500,000 | 32,500,000 | |||
| Additional term loans | 0 | $ 0 | |||
| Debt instrument payment, description | Under the SVB Loan Agreement, the term loans would mature on September 1, 2029, and would be subject to monthly interest only payments until September 30, 2027, provided the Company achieved both a certain financial and a certain clinical milestone by June 30, 2026, upon which the term loans would amortize with monthly installments of principal and interest beginning October 1, 2027 until maturity on September 1, 2029. No additional term loans were drawn and the availability of such additional terms loans expired on June 30, 2026. As of June 30, 2026, the $32.5 million term loan remained outstanding under the SVB Loan Agreement. | ||||
| Term loan maturity date | Sep. 01, 2028 | ||||
| Contractual interest rate | 7.00% | ||||
| Prime rate | 0.75% | ||||
| Interest rate | 9.24% | ||||
| Final fee | 5.00% | ||||
| Percentage of loan prepayment fee in first year | 3.00% | ||||
| Percentage of loan prepayment fee in year two | 2.00% | ||||
| Percentage of loan prepayment fee in there after year two | 1.00% | ||||
| Interest expense | $ 700,000 | $ 700,000 | $ 1,400,000 | $ 1,400,000 | |
| Tranche One [Member] | Silicon Valley Bank [Member] | |||||
| Debt Instrument [Line Items] | |||||
| Debt instrument drew | $ 32,500,000 | ||||
| Tranche Two [Member] | Silicon Valley Bank [Member] | |||||
| Debt Instrument [Line Items] | |||||
| Debt instrument remaining borrowing capacity | $ 20,000,000 | ||||
| Maximum [Member] | Silicon Valley Bank [Member] | |||||
| Debt Instrument [Line Items] | |||||
| Contractual interest rate | 9.75% | ||||
| X | ||||||||||
- Definition Additional term loans. No definition available.
|
| X | ||||||||||
- Definition Final Fee Percentage No definition available.
|
| X | ||||||||||
- Definition Percentage of loan prepayment fee in after year two No definition available.
|
| X | ||||||||||
- Definition Percentage of loan prepayment fee in twelve months. No definition available.
|
| X | ||||||||||
- Definition Percentage of loan prepayment fee in year two. No definition available.
|
| X | ||||||||||
- Definition Percentage points added to the reference rate to compute the variable rate on the debt instrument. No definition available.
|
| X | ||||||||||
- Definition Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The average effective interest rate during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate amount of interest paid or due on all long-term debt. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|